[
    [
        {
            "time": "2021-03-01",
            "original_text": "Pfizer and BioNTech's Coronavirus Vaccine Remains Effective for at Least 6 Months",
            "features": {
                "keywords": [
                    "Pfizer",
                    "BioNTech",
                    "vaccine",
                    "effective",
                    "6 months"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pfizer and BioNTech's Coronavirus Vaccine Remains Effective for at Least 6 Months",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-05",
            "original_text": "BioNTech Stock Hikes As Pfizer-Partnered Covid Vaccine Appears Durable",
            "features": {
                "keywords": [
                    "BioNTech",
                    "stock",
                    "hikes",
                    "Pfizer",
                    "Covid",
                    "vaccine",
                    "durable"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "BioNTech Stock Hikes As Pfizer-Partnered Covid Vaccine Appears Durable",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-10",
            "original_text": "Pfizer Trials Show Vaccine Is Effective for At Least Six Months",
            "features": {
                "keywords": [
                    "Pfizer",
                    "trials",
                    "vaccine",
                    "effective",
                    "six months"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pfizer Trials Show Vaccine Is Effective for At Least Six Months",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-15",
            "original_text": "UPDATE 3-Pfizer/BioNTech COVID-19 shot 91% effective in updated data, protective against South African variant",
            "features": {
                "keywords": [
                    "Pfizer",
                    "BioNTech",
                    "COVID-19",
                    "shot",
                    "91%",
                    "effective",
                    "South African variant"
                ],
                "sentiment_score": 0.88,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "UPDATE 3-Pfizer/BioNTech COVID-19 shot 91% effective in updated data, protective against South African variant",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-03-20",
            "original_text": "Pfizer Suggests Covid Vaccine Can Tackle South Africa Variant; BioNTech Pops",
            "features": {
                "keywords": [
                    "Pfizer",
                    "Covid",
                    "vaccine",
                    "South Africa Variant",
                    "BioNTech",
                    "pops"
                ],
                "sentiment_score": 0.87,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pfizer Suggests Covid Vaccine Can Tackle South Africa Variant; BioNTech Pops",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-25",
            "original_text": "Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study",
            "features": {
                "keywords": [
                    "Pfizer",
                    "BioNTech",
                    "high efficacy",
                    "safety",
                    "six months",
                    "second dose",
                    "COVID-19"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 10,
                "Entity_Density": 10,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]